Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients

C. Lemos, E. Giovannetti, P.A. Zucali, Y.G. Assaraf, G.L. Scheffer, T. van der Straaten, A. D'Incecco, A. Falcone, H.J. Guchelaar, R. Danesi, A. Santoro, G. Giaccone, C. Tibaldi, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

49 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)159-170
Issue number2
Publication statusPublished - 2011

Cite this